CYSLTR1 and cancer: In a study with HT-29 and SW-480, montelukast prevented LTD4-induced colony formation and disrupted colonospheres as well as downregulation of cancer stem cell markers (ALDH1 and DCLK1), suggesting the beneficial effect in minimizing cancer stem cells of CysLT1R inhibition [57].